Quantcast
 
New book by Larry Connors - Click here to read more


VRUS

VRUS: To Present At Lazard Capital Healthcare Conference @ 08:55 ET [delayed] - 11/18 - 08:24 AM ET

VRUS: To Present At Rodman & Renshaw Investment Conference @ 12:25 ET [delayed] - 11/11 - 10:53 AM ET

Pharmasset to Present at Two Upcoming Investor Conferences - 11/10 - 06:45 AM ET

Pharmasset to Webcast an Investor Event from the AASLD Meeting - 10/28 - 07:30 AM ET

Pharmasset, Inc. (VRUS) Corporate Event Announcement Notice - 10/27 - 09:14 PM ET

Pharmasset to Present at the Natixis Bleichroeder Hidden Gems Conference on Monday, October 13th - 10/08 - 07:30 AM ET

VRUS: To Present At JMP Securities Healthcare Conference @ 10:00 ET [delayed] - 10/06 - 08:53 AM ET

Richard E.T. Smith, Ph.D. Joins Pharmasset as Vice President of Investor Relations and Corporate Communications - 10/06 - 07:30 AM ET

Pharmasset to Present at the JMP Securities Healthcare Focus Conference on Monday, October 6th - 10/01 - 07:30 AM ET

VRUS: To Present At UBS Global Life Sciences Conference @ 16:00 ET [delayed] - 09/24 - 02:23 PM ET

VRUS: Positive Preliminary Results from Ph 1 Trial of R7128 for Hepatitis C - 09/08 - 08:21 AM ET

Pharmasset Reports Preliminary Results of a 4-week Proof-of-Concept Combination Study of R7128 for the Treatment of Chronic Hepatitis C in Genotype 2 or 3 Non-Responders - 09/08 - 07:00 AM ET

Pharmasset Reports Financial Results for Quarter Ended June 30, 2008 - 08/14 - 04:01 PM ET

VRUS: To Present At Canaccord Adams Global Growth Conference @ 11:30 ET [delayed] - 08/12 - 09:53 AM ET

Pharmasset to Present at the Canaccord Adams Global Growth Conference on Tuesday, August 12th - 08/08 - 04:14 PM ET

VRUS: Announces Preliminary Results of Third Cohort in Ph I Trial of R7128 - 08/05 - 09:30 AM ET

Pharmasset Reports Preliminary Results of a 4-week Combination Study of R7128 for the Treatment of Chronic Hepatitis C - 08/05 - 07:00 AM ET

Pharmasset Joins Russell 3000 Index - 07/01 - 08:59 AM ET

Pharmasset Receives Notice of Allowance - 06/26 - 07:00 AM ET

Zelos Therapeutics Appoints Alan S. Roemer as Chief Financial Officer - 06/17 - 08:33 AM ET

Page 1 of 5     1  2   3   4   5      Previous  |  Next

<< Back to Stock Index

 

Most Popular News
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2008 The Connors Group, Inc.